Frontier Institute

Spokane, Washington 99204

0 studies enrolling now · 7 studies all time

What they study most

Major Depressive Disorder, Major Depressive Disorder (MDD), Schizoaffective Disorder, Schizophrenia

Studies at this site

• Vortioxetine, 5, 10, and 20 mg, Relapse Prevention Study in Adults With Major Depressive Disorder (MDD) — Completed
• Open-label Long Term (52 Weeks) Safety and Tolerability of Agomelatine Sublingual Tablets in Major Depressive Disorder (MDD) — Stopped early
• Genomics Used to Improve DEpression Decisions — Completed
• A Comparison of Long-acting Injectable Medications for Schizophrenia — Completed
• PEARL Schizophrenia Maintenance — Completed
• Brexpiprazole as Adjunctive Therapy With Major Depressive Disorder and an Inadequate Response to Previous Adjunctive Therapy — Completed
• Switching to Iloperidone From Other Antipsychotics in Schizophrenia — Completed